Home / Conferences / Programme
Conference
Programme
We are returning to the Radisson Red Hotel, Bath Road, near Heathrow, UB7 0DU, on 25th September for the 2026 conference.
Friday 25th September
14.00
Registration
16.00
Tea/cake & Meet-up
18.30
Drinks reception
19.30
Dinner
21.00
Keynote Speaker: Dr Tom Newsom-Davis, Consultant Oncologist, Chelsea & Westminster Hospital, Chair of British Thoracic Oncology Group Steering Committee
Saturday 26th September
8.00-9.00
Breakfast
9.00-9.30
Day delegate registration
9.15
Regional Ambassadors meeting with Chair
9.45
Welcome: Ms Debra Montague, Chair, ALK Positive UK plus Professor Sanjay Popat video.
10.00
Clinical Trials: Dr Sharmistha Ghosh, Consultant Oncologist, Guy's & St Thomas' Hospital, London
10.45
Tea/coffee
11.15
Cancer Signalling Pathways: Richard Bayliss, School of Molecular & Cellular Biology, Leeds University
12.00
Survivorship - Dr Natalie Doyle, former Nurse Consultant, Living With and Beyond Cancer, The Royal Marsden Hospital, London
12.45
Lunch
13.45
Travel Insurance: Ms Fiona Macrae, founder Insurewith
14.30
Patient Voices: Panel discussion hosted by Emma Britton, radio presenter and patient
15.15
Tea/coffee
15.45
Managing Side Effects and progression:
Breakout session -
Lorlatinib: Professor Alastair Greystoke, Professor of Oncology, Newcastle University
Other TKIs: Dr Joanne Evans, Consultant Oncologist, Imperial College London
16.45
Close
18.30
Drinks reception
17.30
Dinner
Sunday 27th September
8.00-9.00
Breakfast
9.15
Update from the Charity: Ms Debra Montague
Update on her research: Ms Roxane Chen
10.15
Advice from the Pharmacy: Ms Rachel Patel, Oncology Pharmacist, One Devon NHS Trust
11.00
Tea/coffee
11.30
Open Questions & Answers: Dr Shobhit Baijal, Consultant Oncologist, University Hospital, Birmingham
12.30
Close, Lunch and Depart
Grateful Acknowledgements
This conference is supported by grants from Roche Products Limited, Pfizer UK, Takeda Pharmaceuticals and donations from Emma Britton, Libby Thirwell, Kevin O'Connell and Ross Bissell. These organisations and individuals have had no control over the content of the conference.
